Prevention of Recurrence After Resection of Hepatocellular Carcinoma: A Daunting Challenge

被引：112
作者：
Poon, Ronnie T. P. [1 ]
机构：
[1] Univ Hong Kong, Queen Mary Hosp, Dept Surg, Hong Kong, Hong Kong, Peoples R China
来源：
HEPATOLOGY | 2011年 / 54卷 / 03期
关键词：
CURATIVE RESECTION; RANDOMIZED-TRIAL; RISK-FACTORS; INTERFERON; VITAMIN-K2; METAANALYSIS; EXPRESSION; HEPATITIS; THERAPY; LIVER;
D O I：
10.1002/hep.24569
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：757 / 759
页数：3
相关论文
共 21 条
[1]   Systematic review and meta-analysis of interferon after curative treatment of hepatocellular carcinoma in patients with viral hepatitis [J].
Breitenstein, S. ;
Dimitroulis, D. ;
Petrowsky, H. ;
Puhan, M. A. ;
Muellhaupt, B. ;
Clavien, P. -A. .
BRITISH JOURNAL OF SURGERY, 2009, 96 (09) :975-981
[2]   Continuous Improvement of Survival Outcomes of Resection of Hepatocellular Carcinoma A 20-Year Experience [J].
Fan, Sheung Tat ;
Lo, Chung Mau ;
Poon, Ronnie T. P. ;
Yeung, Chun ;
Liu, Chi Leung ;
Yuen, Wai Key ;
Lam, Chi Ming ;
Ng, Kelvin K. C. ;
Chan, See Ching .
ANNALS OF SURGERY, 2011, 253 (04) :745-758
[3]   Role of vitamin K2 in the development of hepatocellular carcinoma in women with viral cirrhosis of the liver [J].
Habu, D ;
Shiomi, S ;
Tamori, A ;
Takeda, T ;
Tanaka, T ;
Kubo, S ;
Nishiguchi, S .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (03) :358-361
[4]  
Hotta N, 2007, HEPATO-GASTROENTEROL, V54, P2073
[5]   Preventive effects of vitamin K on recurrent disease in patients with hepatocellular carcinoma arising from hepatitis C viral infection [J].
Kakizaki, Satoru ;
Sohara, Naondo ;
Sato, Ken ;
Suzuki, Hideyuki ;
Yanagisawa, Masatoshi ;
Nakajima, Hiroaki ;
Takagi, Hitoshi ;
Naganuma, Atsushi ;
Otsuka, Toshiyuki ;
Takahashi, Hitomi ;
Hamada, Tetsuya ;
Mori, Masatomo .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 (04) :518-522
[6]  
Kuriyama S, 2005, INT J ONCOL, V27, P505
[7]   Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial [J].
Lau, WY ;
Leung, TWT ;
Ho, SKW ;
Chan, M ;
Machin, D ;
Lau, J ;
Chan, ATC ;
Yeo, W ;
Mok, TSK ;
Yu, SCH ;
Leung, NWY ;
Johnson, PJ .
LANCET, 1999, 353 (9155) :797-801
[8]   Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: A randomized phase II trial for safety and optimal dosage [J].
Liu, Chun-Jen ;
Lee, Po-Huang ;
Lin, Deng-Yn ;
Wu, Cheng-Chung ;
Jeng, Long-Bin ;
Lin, Pin-Wen ;
Mok, King-Tong ;
Lee, Wei-Chen ;
Yeh, Hong-Zen ;
Ho, Ming-Chih ;
Yang, Sheng-Shun ;
Lee, Ching-Chih ;
Yu, Ming-Chin ;
Hu, Rey-Heng ;
Peng, Cheng-Yuan ;
Lai, Kuan-Lang ;
Chang, Stanley Shi-Chung ;
Chen, Pei-Jer .
JOURNAL OF HEPATOLOGY, 2009, 50 (05) :958-968
[9]   Sorafenib in advanced hepatocellular carcinoma [J].
Llovet, Josep M. ;
Ricci, Sergio ;
Mazzaferro, Vincenzo ;
Hilgard, Philip ;
Gane, Edward ;
Blanc, Jean-Frederic ;
Cosme de Oliveira, Andre ;
Santoro, Armando ;
Raoul, Jean-Luc ;
Forner, Alejandro ;
Schwartz, Myron ;
Porta, Camillo ;
Zeuzem, Stefan ;
Bolondi, Luigi ;
Greten, Tim F. ;
Galle, Peter R. ;
Seitz, Jean-Francois ;
Borbath, Ivan ;
Haussinger, Dieter ;
Giannaris, Tom ;
Shan, Minghua ;
Moscovici, Marius ;
Voliotis, Dimitris ;
Bruix, Jordi .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (04) :378-390
[10]   A randomized, controlled trial of postoperative adjuvant interferon therapy after resection of hepatocellular carcinoma [J].
Lo, Chung Mau ;
Liu, Chi Leung ;
Chan, See Ching ;
Lam, Chi Ming ;
Poon, Ronnie T. P. ;
Ng, Irene O. L. ;
Fan, Sheung Tat ;
Wong, John .
ANNALS OF SURGERY, 2007, 245 (06) :831-842
123